Stay updated on FRIDA Clinical Trial: Iadademstat & Gilteritinib in FLT3 Mut+ AML
Sign up to get notified when there's something new on the FRIDA Clinical Trial: Iadademstat & Gilteritinib in FLT3 Mut+ AML page.

Latest updates to the FRIDA Clinical Trial: Iadademstat & Gilteritinib in FLT3 Mut+ AML page
- Check2 days agoChange DetectedA new revision entry v3.5.4 was added to the study record history and the previous revision v3.5.3 was removed, signaling a minor update to the page’s version history rather than substantive content changes.SummaryDifference0.1%

- Check9 days agoNo Change Detected
- Check16 days agoChange DetectedA new revision entry for v3.5.3 was added to the Record History, superseding the prior v3.5.2.SummaryDifference0.1%

- Check23 days agoNo Change Detected
- Check31 days agoChange DetectedThe study record history shows an added revision v3.5.2 and removal of the earlier revision v3.5.0.SummaryDifference0.1%

- Check59 days agoChange DetectedFooter revision updated from v3.4.3 to v3.5.0.SummaryDifference0.1%

- Check66 days agoChange DetectedRevision history now shows the addition of v3.4.3 and the removal of v3.4.2 in the study record history.SummaryDifference0.1%

- Check73 days agoChange DetectedVersion history shows updates to study status and location data across versions, including changes to recruitment status and site entries.SummaryDifference0.1%

Stay in the know with updates to FRIDA Clinical Trial: Iadademstat & Gilteritinib in FLT3 Mut+ AML
Enter your email address, and we'll notify you when there's something new on the FRIDA Clinical Trial: Iadademstat & Gilteritinib in FLT3 Mut+ AML page.